NEW DELHI (3 March 2026) — A comprehensive study published in The Lancet Oncology has revealed a staggering rise in breast cancer cases in India, with an increase of nearly 477% between 1990 and 2023. The research, led by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, highlights the escalating burden of the disease as a leading cause of mortality and morbidity among women in the country.
The Indian Context: A “Staggering” Increase
According to the study’s lead author, Kayleigh Bhangdia, India registered approximately 2.03 lakh new breast cancer cases in 2023. This represents a massive jump from 1990 levels, accompanied by a 352.3% increase in deaths, which surpassed 1 lakh annually in 2023.
Key Statistics for India (1990–2023):
- New Cases: ~2.03 Lakh (477% increase)
- Annual Deaths: >1 Lakh (352% increase)
- Trend: The disease is increasingly affecting younger women in India compared to Western nations, with a significant peak in the 40–50 age group.
Global Projections: The Road to 2050
The study estimates that the global burden of breast cancer will continue to intensify over the next three decades, driven by aging populations and lifestyle shifts.
| Metric | 2023 (Actual) | 2050 (Projected) | % Change |
| Global New Cases | 2.3 Million | 3.5 Million | +33% |
| Global Annual Deaths | 9.5 Lakh | 1.37 Million | +44% |
Factors Driving the Surge
Experts attribute the dramatic rise in India to several socio-economic and lifestyle transitions:
- Late Marriage and Motherhood: Delayed childbearing and shorter breastfeeding durations are known risk factors.
- Urbanization and Diet: Increased consumption of processed foods and sedentary lifestyles contributing to higher BMI (Body Mass Index).
- Late Diagnosis: Due to a lack of awareness and screening infrastructure, over 50% of breast cancer cases in India are diagnosed at advanced stages (Stage III or IV), significantly lowering survival rates.
- Environmental Factors: Increasing exposure to endocrine-disrupting chemicals and pollution in rapidly growing urban centers.
Call for Action: Early Detection is Key
The IHME researchers emphasized that while the numbers are daunting, breast cancer is highly treatable if caught early. The study advocates for:
- Universal Screening: Implementation of cost-effective clinical breast exams at the primary healthcare level.
- Public Awareness: De-stigmatizing the disease to encourage women to report lumps or changes immediately.
- Treatment Access: Reducing the “treatment gap” between urban and rural India to ensure specialized oncology care is reachable for all.
Sources
- The Lancet Oncology: “Global, regional, and national burden of breast cancer, 1990–2050” (March 2026)
- Press Trust of India (PTI): “Nearly 500 per cent increase in breast cancer cases in India since 1990: Study” (March 3, 2026)
- Institute for Health Metrics and Evaluation (IHME): Official Data Release on India Cancer Burden (2026)
- The Indian Express: “Why breast cancer cases are surging among younger Indian women” (March 4, 2026)
- University of Washington: “IHME study projects 3.5 million breast cancer cases by 2050” (March 2, 2026)
Leave a Reply